PatientsLikeMe ™
Already a member? Log in
with patients just like you.
- Filter page content by community
- MS
-
Find out more about the PatientsLikeMe
MS Community
Scopolamine Transdermal Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Transderm Scop
See also:
Scopolamine
What is Scopolamine Transdermal?
Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is used to reduce excessive saliva and oral secretions.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
3 patients in the community are taking or have taken Scopolamine Transdermal.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Vertigo | 1 | 33% |
| disease-related symptoms | 1 | 33% |
Dosages
Based on the patients currently taking Scopolamine Transdermal.
| 1.5 mg day | ||
|---|---|---|
1
|
||
Duration
How long current patients have been taking Scopolamine Transdermal or how long patients were taking Scopolamine Transdermal before stopping.
Currently taking Scopolamine Transdermal
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Stopped taking Scopolamine Transdermal
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Patient Reported Evaluations
Results from 1 patient evaluation. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| None | 100% | 1 |
|---|
Vertigo
Side-effects (as an overall problem)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 0% | 0 |
| None | 100% | 1 |
Top reported side-effects include: skin irritation
Summary results are based on 1 individual response. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (1 of 1)
-
- Dymond
- Sensation: Moderate
- Overall: None
- Cognition: none
- Vision: mild
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: none
- See profile
-
by Dymond
Jun 16, 2008
- EfficacyNone
- Side-effectsNone
- Vertigo
- See full evaluation
-
0 helpful marks